Connect in the City of Brotherly Love
TIME100 Health Honoree
David Fajgenbaum, MD, MBA, MSc, is co-Founder & President of Every Cure and a physician-scientist at the University of Pennsylvania, where he is one of the youngest faculty members ever to receive tenure at Penn Medicine. He is also the national bestselling author of Chasing My Cure: A Doctor's Race to Turn Hope Into Action, which is being adapted into a film by Forrest Gump producer Wendy Finerman.
View Full Keynote
Plan Your Visit to Philadelphia
Book your hotel early with DIA's preferred room blocks near the Pennsylvania Convention Center. Experience America's historic city while connecting with peers from around the world.
Book Your Stay →
Conference Highlights
Registration
Secure your spot at DIA 2026 with Early Bird pricing. Choose from multiple registration types to match your professional needs and budget.
Register TodayAgenda
Explore the full conference agenda with session details, speaker information, and personalized scheduling tools to build your ideal DIA 2026 experience.
View Full AgendaShort Courses
Deepen your expertise with intensive half-day and full-day courses led by industry experts on specialized topics in drug development.
Browse Short CoursesDIA Celebrate
Join us for an unforgettable evening celebrating innovation, collaboration, and the DIA community at our signature networking event.
Learn About CelebrateLift Series
Elevate your expertise with focused learning tracks designed to advance your skills and knowledge in key therapeutic and functional areas.
Explore Lift SeriesNetworking Experiences
Connect with 4,100+ global professionals across structured and informal networking formats designed to spark new collaborations.
Explore the ExchangeInteractive Learning
Dive into hands-on workshops, case studies, and solution-focused sessions that you can immediately apply in your role.
Browse TracksGet Involved
Discover industry insights, emerging trends, and real-world solutions from global experts across a wide range of therapeutic and functional areas.
Submit TodayTravel & Hotel
Plan your stay in Philadelphia with special DIA room blocks and convenient access to the Pennsylvania Convention Center.
View Travel InformationWhat Attendees Say
Discover how DIA's Global Annual Meeting has transformed careers, sparked collaborations, and advanced the life sciences community year after year.
The DIA meeting is so incredibly valuable from a professional standpoint for the networking, the content… it's really super valuable, it's a must-attend meeting.
Program Committee
Program Committee members help bridge sectors, disciplines, and perspectives while connecting science, regulation, and innovation to shape a cohesive and forward-looking DIA 2026 program.
Program Committee
-
Representative Invited • FDA, United States
-
Amy Bertha • Executive Director, Regulatory Policy and Science
Bayer, United States -
Sanghita Bhattacharya, PhD • Director Data Science Global Function
Johnson & Johnson, United States -
Asia Blackwell • Consumer Safety Officer, CBER
FDA, United States -
Tywnia Brewton • Executive Director, Human Resources
Astellas , United States -
James Buchanan, PharmD • President
Covilance LLC, United States -
Mandy Kaur Budwal-Jagait, MSc • Head of GCP
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Brooke Casselberry, MS, RAC • Vice President, Advisory and Delivery
Epista Life Science, United States -
Meghana Chalasani, MHA • Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
FDA, United States -
Joan Chambers • Independent Senior Consultant
Tufts Center For the Study of Drug Development, United States -
Rachel Chasse, MS • Associate Director, Digital Science Strategy
AbbVie, United States -
Monica Chiaramonte, PhD • Director, Clinical Regulatory Writing
AstraZeneca, United States -
Christine Colvis, PhD • Director, Drug Development Partnership Programs
National Center for Advancing Translational Sciences (NCATS), United States -
Karen Correa, PhD • Vice President, Clinical Development Operations
Boehringer Ingelheim, United States -
Solange Corriol-Rohou, DrMed, MD, PhD •
SCR Consulting, France -
Stephanie Y. Crawford, PhD, MPH, MS • Professor, Pharmacy Systems, Outcomes and Policy
University of Illinois at Chicago, United States -
Alysha Croker, PhD • Director, Strategic and Horizontal Policy
Health Canada, Canada -
Matthew Curin, PharmD • Sr. Dir, Head of Program Management, Therapeutic Dermatology
Galderma, United States -
Representative Invited • FDA, United States
-
Victoria DiBiaso, BSN, MPH, RN • Global Head, Patient Informed Development and Health Value Translation
Sanofi, France -
Megan Doyle, JD, MPH • Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly and Company, United States -
Nancy A Dreyer, PhD, MPH, FISPE • Founder
Dreyer Strategies LLC, United States -
Joseph Dustin • Founder and Principal
Dauntless Eclinical Strategies, United States -
Jennifer Emerson, PhD, MPH, RN, PMP • Head Quality Analytics & Risk Management
Boehringer Ingelheim, Germany -
Andrew Emmett, MPH • VP, Global Regulatory Policy and Global Intelligence
Pfizer, United States -
Celeste Frankenfeld Lamm • Senior Director, Global Regulatory Affairs – CMC
Merck & Co., Inc., United States -
Danielle Friend Economo, PhD • Senior Director, US Head Regulatory Policy and Intelligence
Johnson & Johnson, United States -
David Fryrear, MS • Chief Quality Officer
Astellas, United States -
Cheryl Grandinetti, PharmD • Associate Director for Clinical Policy, CDER/OC/OSI/DCCE
FDA, United States -
Courtney Granville, PhD, MPH •
United States -
Lani Hashimoto • Consultant, Patient Experience
Hashimoto Consulting Services, United States -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Cammilla Horta Gomes, MA, MPharm • Latam Regulatory Policy Lead
Roche, Brazil -
Stacy Hurt, MBA, MHA • Chief Patient Officer
Parexel, United States -
Huong Huynh, PhD • Director of Regulatory Science
Critical Path Institute, United States -
Jeremy Jokinen, PhD, MS • Vice President and Head Global Patient Safety
Argenx, United States -
Yatika Kohli, PhD, MBA • Chief Compliance and Strategy Officer
NoNO Inc, Canada -
Dominique Lagrave, PharmD • Chief Regulatory Officer
Accumulus Technologies, United States -
Elizabeth Lange, MPH, MS • Executive Director/ Head of Regulatory Scientific Policy
EMD Serono, United States -
Jingyu (Julia) Luan, PhD • Executive Regulatory Science Director, BioPharmaceuticals R&D
AstraZeneca, United States -
Demetra Macheras, MBA • Director, Regulatory Policy and Intelligence - Regulatory Affairs
AbbVie, United States -
Lindsay McNair, MD, MPH, MS • Principal Consultant
Equipoise Consulting, United States -
David Meats • Director, Regulatory Services & Medical Affairs Management
Certara, United States -
Timothe Menard, PharmD, MSc • Global Head, Quality Excellence Digital | Bioethics Ambassador
F. Hoffmann-La Roche Ltd, Switzerland -
Pallavi Mishra-Kalyani, PhD, MS • Deputy Division Director, DBV, OB, CDER
FDA, United States -
May F Mo, MBA, MS • Executive Director, Biostatistics
Amgen, United States -
Monica Munoz, PharmD, PhD • Division Director, Division of Pharmacovigilance-I, OSE, CDER
FDA, United States -
Lauren Oliva, PharmD, RPh • US Regulatory Policy Lead
Biogen, United States -
Representative Invited • FDA, United States
-
Vada Perkins, DrSc, MSc • Vice President, Global Head of Regulatory Intelligence & Policy
Boehringer Ingelheim, United States -
Regina Lynn Preciado • VP, Content Strategy Solutions
Content Rules, Inc., United States -
Ranjini Prithviraj, PhD, PMP • Director, Global Medical Affairs, Publication Management
Regeneron, United States -
Kim Ribeiro, MS • Director Patient Experience & Engagement
Boehringer Ingelheim, United States -
Leslie Sam • President
Leslie Sam and Associates, LLC, United States -
Earl Seltzer, MBA • Senior Director, Partnerships and Innovation
CTI, United States -
Anjali Shah, PharmD • Executive Director, Business Capabilities and Innovation, WWPS
Bristol Myers Squibb, United States -
Cary Smithson, MBA • Managing Partner and Owner
LeapAhead Solutions, Inc., United States -
Elizabeth Somers, MS • Associate Vice President, Global Project and Alliance Management
Merck & Co., Inc., United States -
Benjamin Stevens, PhD, MPH • Director CMC Policy and Advocacy
GlaxoSmithKline, United States -
Nancy Linda Styple • Project Management Leader
Bayer, United States -
Ling Su, PhD • Research Fellow
Yeehong Business School, China -
John Z. Sun, PhD, MBA, PMP • Program Lead, Global Clinical Operation, Development
Novartis, United States -
Michael Torok, PhD • Vice President, Global Head of Quality Assurance Programs
Genentech, A Member of the Roche Group, United States -
Phil Tregunno • Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Representative Invited • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
-
James Valentine, JD, MHS • Director
Hyman, Phelps & McNamara, PC, United States -
James Wabby, MHS • Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States -
Paula Walker, MA • Global Head of Risk Based Quality Management
Roche, United Kingdom -
Robin Whitsell • President
Whitsell Innovations, Inc., United States -
Amira Deia Younes • Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
MSD, United Arab Emirates
